BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kiselev IS, Kulakova OG, Boyko AN, Favorova OO. DNA Methylation As an Epigenetic Mechanism in the Development of Multiple Sclerosis. Acta Naturae 2021;13:45-57. [PMID: 34377555 DOI: 10.32607/actanaturae.11043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bingen JM, Clark LV, Band MR, Munzir I, Carrithers MD. Differential DNA methylation associated with multiple sclerosis and disease modifying treatments in an underrepresented minority population. Front Genet 2022;13:1058817. [PMID: 36685876 DOI: 10.3389/fgene.2022.1058817] [Reference Citation Analysis]
2 Kiselev I, Danilova L, Baulina N, Baturina O, Kabilov M, Boyko A, Kulakova O, Favorova O. Genome-wide DNA methylation profiling identifies epigenetic changes in CD4+ and CD14+ cells of multiple sclerosis patients. Mult Scler Relat Disord 2022;60:103714. [PMID: 35245816 DOI: 10.1016/j.msard.2022.103714] [Reference Citation Analysis]
3 Perdaens O, van Pesch V. Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis. Front Neurol 2022;12:811518. [DOI: 10.3389/fneur.2021.811518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]